New Test for Diagnosing Invasive Candidiasis
Author Information
Author(s): Laín Ana, Elguezabal Natalia, Brena Sonia, García-Ruiz Juan Carlos, del Palacio Amalia, Moragues María D, Pontón José
Primary Institution: Universidad del País Vasco
Hypothesis
Can an ELISA test using a recombinant fragment of Candida albicans Hwp1 improve the diagnosis of invasive candidiasis?
Conclusion
The ELISA test for antibodies against the N-terminal fragment of Hwp1 provides a reliable method for diagnosing invasive candidiasis.
Supporting Evidence
- ELISA test showed a sensitivity of 88.9% for diagnosing invasive candidiasis.
- Immunoblotting had a much lower sensitivity of 27.8%.
- Patients infected with C. albicans had higher antibody titers compared to those with non-albicans species.
Takeaway
Doctors can use a new blood test to find out if someone has a serious yeast infection called invasive candidiasis, which is hard to diagnose.
Methodology
The study involved testing sera from patients using immunoblotting and ELISA to detect antibodies against a recombinant N-terminal fragment of Hwp1.
Potential Biases
Potential bias in patient selection and the retrospective nature of the study.
Limitations
The study's findings may not be generalizable to all patient populations, particularly those with non-albicans Candida infections.
Participant Demographics
Patients included 81 adults, primarily from hematological cancer or Intensive Care Unit backgrounds.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website